Active Gastrointestinal and Other Cancers Grants

PI Namesort descending Organization - Company Title Project Number Major Program / Research Group FOA
Allen, Peter J Duke University Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) 5R01CA235677-02 PAR-18-559
Cao, Yin Washington University Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia 1R37CA246175-01A1 PA-19-056
Chak, Amitabh Case Western Reserve University Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma 5U54CA163060-09 Barrett's Esophagus Translational Research Network RFA-CA-16-006
Chan, Andrew T Massachusetts General Hospital Precision Prevention Research Program 1R35CA253185-01 PAR-19-349
Chan, Andrew T Massachusetts General Hospital Inflammation and Colorectal Neoplasia 5R01CA137178-10 PA-13-302
Chang, Su-Hsin Washington University Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective 1R01CA253475-01 PAR-19-279
Lampe, Johanna W Fred Hutchinson Cancer Research Center Aspirin and Gut Biology: Mucosal Proteomics and Metabolomics in a Randomized Trial 5R01CA222972-02 PA-16-160
Lipkin, Steven M Weill Medical Coll Of Cornell Univ (PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance 5R01CA231283-03 RFA-CA-17-017
Markowitz, Sanford D. Case Western Reserve University Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment 5R35CA197442-04 PAR-15-342
Moyer, Matthew T. Pennsylvania State Univ Hershey Med Ctr CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial 5R01CA222648-03 PA-16-160
Sepulveda, Antonia Rogado George Washington University Mechanisms and Genomics of Esophageal Carcinogenesis 5R01CA208711-06 Provocative Questions RFA-CA-15-008
Smith, Jill P Georgetown University Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent 5R21CA241007-02 PAR-18-020
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome 5R01CA219463-04 RFA-CA-15-008
Waldman, Scott A Thomas Jefferson University Guanylin GUCY2C axis in Colorectal Cancer Initiation 5R01CA204481-04 PA-13-302
Waldman, Scott A Thomas Jefferson University (PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation 5R01CA206026-05 Provocative Questions RFA-CA-15-008

Pages